Review paper
An Overview of the Safety Profile, Advantages and Disadvantages of mRNA Based Vaccines in the SARS-CoV-2 Pandemic
Volume: 1, Issue: 4, Pages: 30 - 40
Published: Feb 4, 2021
Abstract
Messenger ribonucleic acid (mRNA) gene expression and vaccine technology has certain advantages and disadvantages compared to traditional vaccine methods (live attenuated, inactive, protein subunit) and new generation systems (DNA-deoxyribonucleic acid-and viral vectors).mRNA vaccines have a design advantage since the expression system needs to cross a single barrier (cell membrane) and reach the ribosomes, also there is no risk of insertional...
Paper Details
Title
An Overview of the Safety Profile, Advantages and Disadvantages of mRNA Based Vaccines in the SARS-CoV-2 Pandemic
Published Date
Feb 4, 2021
Volume
1
Issue
4
Pages
30 - 40
References31
Original paper
# 1Fernando P. Polack(SUNY Upstate Medical University)
46
# 2Stephen J. Thomas(SUNY Upstate Medical University)
53
Last. William C. Gruber(SUNY Upstate Medical University)
68
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently.MethodsIn an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 days apart, of either placebo or the BNT162b2 vaccine cand...
Original paper
# 1Mitsutoshi Yoneyama(Tokyo Metropolitan Institute of Medical Science)
46
# 2Mika Kikuchi(Tokyo Metropolitan Institute of Medical Science)
8
Last. Takashi Fujita(Tokyo Metropolitan Institute of Medical Science)
91
Intracellular double-stranded RNA (dsRNA) is a chief sign of replication for many viruses. Host mechanisms detect the dsRNA and initiate antiviral responses. In this report, we identify retinoic acid inducible gene I (RIG-I), which encodes a DExD/H box RNA helicase that contains a caspase recruitment domain, as an essential regulator for dsRNA-induced signaling, as assessed by functional screening and assays. A helicase domain with intact ATPase activity was responsible for the dsRNA-mediated si...
Original paper
# 1Uğur Şahin(BioNTech (Germany))
87
# 2Evelyna Derhovanessian(BioNTech (Germany))
39
Last. Barbara Schrörs(Johannes Gutenberg University Mainz)
14
The authors report the first-in-human application of personalized neo-antigen RNA vaccines in patients with melanoma. Neoantigens have long been considered optimal targets for anti-tumour vaccines, and recent mutation coding and prediction techniques have aimed to streamline their identification and selection. Two papers in this issue report results from personalized neoantigen vaccine trials in patients with cancer. Catherine Wu and colleagues report the results of a phase I trial of a personal...
Review paper
# 1Argyrios N. Theofilopoulos(TSRI: Scripps Research Institute)
68
# 2Roberto Baccalà(TSRI: Scripps Research Institute)
31
Last. Dwight H. Kono(TSRI: Scripps Research Institute)
41
▪ Abstract The significance of type I interferons (IFN-α/β) in biology and medicine renders research on their activities continuously relevant to our understanding of normal and abnormal (auto) immune responses. This relevance is bolstered by discoveries that unambiguously establish IFN-α/β, among the multitude of cytokines, as dominant in defining qualitative and quantitative characteristics of innate and adaptive immune processes. Recent advances elucidating the biology of these key cytokines ...
Original paper
# 1Frank O. Nestlé(USZ: University Hospital of Zurich)
78
# 2Curdin Conrad(USZ: University Hospital of Zurich)
41
Last. Michel Gilliet(USZ: University Hospital of Zurich)
51
Psoriasis is one of the most common T cell–mediated autoimmune diseases in humans. Although a role for the innate immune system in driving the autoimmune T cell cascade has been proposed, its nature remains elusive. We show that plasmacytoid predendritic cells (PDCs), the natural interferon (IFN)-α–producing cells, infiltrate the skin of psoriatic patients and become activated to produce IFN-α early during disease formation. In a xenograft model of human psoriasis, we demonstrate that blocking I...
Review paper
# 1Uğur Şahin(BioNTech (Germany))
87
# 2Özlem Türeci
67
Cancer is characterized by an accumulation of genetic alterations. Somatic mutations can generate cancer-specific neoepitopes that are recognized by autologous T cells as foreign and constitute ideal cancer vaccine targets. Every tumor has its own unique composition of mutations, with only a small fraction shared between patients. Technological advances in genomics, data science, and cancer immunotherapy now enable the rapid mapping of the mutations within a genome, rational selection of vaccine...
Original paper
# 1Katalin Karikó(University of Pennsylvania)
48
# 2Hiromi Muramatsu(University of Pennsylvania)
29
Last. Drew Weissman(University of Pennsylvania)
71
In vitro-transcribed mRNA has great therapeutic potential to transiently express the encoded protein without the adverse effects of viral and DNA-based constructs. Mammalian cells, however, contain RNA sensors of the innate immune system that must be considered in the generation of therapeutic RNA. Incorporation of modified nucleosides both reduces innate immune activation and increases translation of mRNA, but residual induction of type I interferons (IFNs) and proinflammatory cytokines remains...
Original paper
# 1Christian Kannemeier(Behringwerke (Germany))
5
# 2Aya Shibamiya(JLU: University of Giessen)
14
Last. Klaus T. Preissner(JLU: University of Giessen)
72
Upon vascular injury, locally controlled haemostasis prevents life-threatening blood loss and ensures wound healing. Intracellular material derived from damaged cells at these sites will become exposed to blood components and could contribute to blood coagulation and pathological thrombus formation. So far, the functional and mechanistic consequences of this concept are not understood. Here, we present in vivo and in vitro evidence that different forms of eukaryotic and prokaryotic RNA serve as ...
Original paper
# 1Aleena Banerji(MGH: Massachusetts General Hospital)
52
# 2Paige G. Wickner(BWH: Brigham and Women's Hospital)
25
Last. Elizabeth Phillips(VUMC: Vanderbilt University Medical Center)
5
Original paper
# 1Martin Alberer(LMU: Ludwig-Maximilians-Universität München)
17
# 2Ulrike Gnad-Vogt(CureVac (Germany))
14
Last. Frank von Sonnenburg(LMU: Ludwig-Maximilians-Universität München)
48
Vaccines based on mRNA coding for antigens have been shown to be safe and immunogenic in preclinical models. We aimed to report results of the first-in-human proof-of-concept clinical trial in healthy adults of a prophylactic mRNA-based vaccine encoding rabies virus glycoprotein (CV7201).We did an open-label, uncontrolled, prospective, phase 1 clinical trial at one centre in Munich, Germany. Healthy male and female volunteers (aged 18-40 years) with no history of rabies vaccination were sequenti...
1
2
3
4